Jönsson K - Search Results

1

The cytotoxic effects of 5-OH-1,4-naphthoquinone and 5,8-diOH-1,4-naphthoquinone on doxorubicin-resistant human leukemia cells (HL-60).

Segura-Aguilar J, Jönsson K, Tidefelt U, Paul C. Segura-Aguilar J, et al. Among authors: jonsson k. Leuk Res. 1992 Jun-Jul;16(6-7):631-7. doi: 10.1016/0145-2126(92)90013-w. Leuk Res. 1992. PMID: 1635381

2

Comparison of a bioluminescence assay with differential staining cytotoxicity for cytostatic drug testing in vitro in human leukemic cells.

Rhedin AS, Tidefelt U, Jönsson K, Lundin A, Paul C. Rhedin AS, et al. Among authors: jonsson k. Leuk Res. 1993 Mar;17(3):271-6. doi: 10.1016/0145-2126(93)90011-9. Leuk Res. 1993. PMID: 7680736

3

Characterization of an anthracycline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression.

Jönsson K, Dahlberg N, Tidefelt U, Paul C, Andersson G. Jönsson K, et al. Biochem Pharmacol. 1995 Mar 15;49(6):755-62. doi: 10.1016/0006-2952(94)00511-j. Biochem Pharmacol. 1995. PMID: 7702633

4

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase.

Björkhem-Bergman L, Jönsson K, Eriksson LC, Olsson JM, Lehmann S, Paul C, Björnstedt M. Björkhem-Bergman L, et al. Among authors: jonsson k. Biochem Pharmacol. 2002 May 15;63(10):1875-84. doi: 10.1016/s0006-2952(02)00981-4. Biochem Pharmacol. 2002. PMID: 12034372

5

Identification and characterization of human deoxyguanosine kinase cDNA fragments.

Månsson E, Jönsson K, Albertioni F. Månsson E, et al. Among authors: jonsson k. Cancer Lett. 2001 Sep 20;170(2):147-52. doi: 10.1016/s0304-3835(01)00586-9. Cancer Lett. 2001. PMID: 11463492

6

Absorption of an oxytocin antagonist (antocin) and a vasopressin analogue (dDAVP) through a standardized skin erosion in volunteers.

Lundin S, Svedman P, Höglund P, Jönsson K, Broeders A, Melin P. Lundin S, et al. Among authors: jonsson k. Pharm Res. 1995 Dec;12(12):2024-9. doi: 10.1023/a:1016272729556. Pharm Res. 1995. PMID: 8786983

7

Background pain in burn patients: routine measurement and recording of pain intensity in a burn unit.

Jonsson CE, Holmsten A, Dahlström L, Jonsson K. Jonsson CE, et al. Among authors: jonsson k. Burns. 1998 Aug;24(5):448-54. doi: 10.1016/s0305-4179(98)00050-3. Burns. 1998. PMID: 9725686 Clinical Trial.

8

Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.

Jönsson K, Alfredsson K, Söderberg-Ahlm C, Critchley H, Broeders A, Ohlin M. Jönsson K, et al. Acta Endocrinol (Copenh). 1992 Jul;127(1):27-32. doi: 10.1530/acta.0.1270027. Acta Endocrinol (Copenh). 1992. PMID: 1519419

9

Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist centre.

Jonsson N, Zimmerman M, Chidzonga MM, Jonsson K. Jonsson N, et al. Among authors: jonsson k. Cent Afr J Med. 1998 Feb;44(2):31-4. Cent Afr J Med. 1998. PMID: 9675968

10

The proteolytic effect of pancreatic pseudocyst fluid on vessel walls.

Lasson A, Jönsson K, Lore'n I, Sternby NH. Lasson A, et al. Among authors: jonsson k. Int J Pancreatol. 1994 Aug;16(1):23-9. doi: 10.1007/BF02925606. Int J Pancreatol. 1994. PMID: 7806911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

699 results

Search Page

Filters